Get the Stockscreener App
1.28
4.48%
-0.06
After Hours:
1.35
0.07
+5.47%
Geovax Labs Inc stock is traded at $1.28, with a volume of 64,072.
It is down -4.48% in the last 24 hours and down -25.58% over the past month.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
See More
Previous Close:
$1.34
Open:
$1.34
24h Volume:
64,072
Relative Volume:
0.50
Market Cap:
$2.85M
Revenue:
$3.35M
Net Income/Loss:
$-25.31M
P/E Ratio:
-0.035
EPS:
-36.5794
Net Cash Flow:
$-24.29M
1W Performance:
+8.47%
1M Performance:
-25.58%
6M Performance:
-91.42%
1Y Performance:
-93.98%
1-Day Range:
$1.26
$1.34
1-Week Range:
$1.1368
$1.35
52-Week Range:
$1.1368
$34.75
Geovax Labs Inc Stock (GOVX) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678-384-7220
Address
1900 LAKE PARK DRIVE, SMYRNA
Compare GOVX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
1.28 | 2.98M | 3.35M | -25.31M | -24.29M | -36.58 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Downgrade | D. Boral Capital | Buy → Hold |
| Apr-15-25 | Reiterated | Alliance Global Partners | Buy |
| Apr-15-25 | Reiterated | D. Boral Capital | Buy |
| Nov-11-24 | Initiated | Alliance Global Partners | Buy |
| Jul-16-24 | Initiated | ROTH MKM | Buy |
| Nov-19-20 | Initiated | Maxim Group | Buy |
View All
Geovax Labs Inc Stock (GOVX) Latest News
GeoVax Reports 2025 Year-End Financial Results and Provides Business Update - National Today
GeoVax Advances Mpox/Smallpox Vaccine Toward Phase 3 Trial Amid Global Supply Concerns - citybuzz -
How The GeoVax Labs (GOVX) Story Is Shifting After The Rating Downgrade And Valuation Reset - Yahoo Finance
GeoVax Positions GEO-MVA to Address Supply Constraints in Global Mpox and Smallpox Vaccine Market - Yahoo Finance
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) - ADVFN
Amended Statement of Ownership (sc 13g/a) - ADVFN
Post-effective Amendment to Registration Statement (pos Am) - ADVFN
Annual Report (10-k) - ADVFN
Quarterly Report (10-q) - ADVFN
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
Forecast Cut: What is the long term forecast for GeoVax Labs Inc Equity Warrant stock2026 WrapUp & Smart Swing Trading Techniques - baoquankhu1.vn
GOVX|GeoVax Labs Inc|Price:1.230|Chg%:0.07 - TradingKey
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market Session - Sahm
Movement Recap: How much upside does GeoVax Labs Inc Equity Warrant have2026 Technicals & Short-Term Swing Trade Alerts - baoquankhu1.vn
Published on: 2026-04-09 02:29:52 - baoquankhu1.vn
GOVX Forecast, Price Target & Analyst Ratings | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
Gains Report: What is the long term forecast for GeoVax Labs Inc Equity Warrant stockRate Cut & Intraday High Probability Alerts - baoquankhu1.vn
Momentum Shift: What is GeoVax Labs Incs valuation compared to sectorWeekly Market Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn
GeoVax Highlights Single-Dose Mpox Vaccine Data at World Vaccine Congress 2026 - Yahoo Finance
Geovax Labs Inc (E8LA.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
GOVX Technical Analysis | Trend, Signals & Chart Patterns | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
GeoVax Labs Boosts Liquidity Through Warrant Inducement Financing - TipRanks
GeoVax Labs Delays Annual 10-K Filing - TipRanks
GeoVax Secures $863,000 Through Warrant Inducement Transaction to Fund Vaccine and Immunotherapy Development - citybuzz -
[8-K] GeoVax Labs, Inc. Reports Material Event - Stock Titan
[NT 10-K] GeoVax Labs, Inc. SEC Filing - Stock Titan
GeoVax Announces a Warrant Inducement Transaction - TradingView
Why The GeoVax Labs (GOVX) Story Is Shifting As Valuation Holds And Risks Rise - Yahoo Finance
Aug Summary: What is GeoVax Labs Incs valuation compared to sector2026 Stock Rankings & Safe Entry Point Identification - baoquankhu1.vn
Investment Review: Is GeoVax Labs Inc Equity Warrant a play on infrastructure spendingGold Moves & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Published on: 2026-03-30 03:13:45 - baoquankhu1.vn
GOVX Should I Buy - Intellectia AI
VIX Spike: Is GeoVax Labs Inc Equity Warrant benefiting from interest rate changesPortfolio Return Summary & Community Verified Watchlist Alerts - baoquankhu1.vn
GeoVax Advances Mpox and Smallpox Vaccine Toward Phase 3 Trial with Clinical Supply Milestone - citybuzz -
Panic Selling: Does GeoVax Labs Inc Equity Warrant align with a passive investing strategy2026 Trading Volume Trends & Accurate Buy Signal Notifications - baoquankhu1.vn
GeoVax Provides Update on GEO-MVA Program - Yahoo Finance
Ideas Watch: Is GeoVax Labs Inc Equity Warrants ROE strong enoughPortfolio Performance Summary & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
GOVX Stock Price, Quote & Chart | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
GeoVax Labs Inc expected to post a loss of $6.17 a shareEarnings Preview - TradingView
Certain Warrants of GeoVax Labs, Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
30,058,786 Common Stock of GeoVax Labs, Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - MarketScreener
If You Invested $1,000 in Geovax Labs Inc (GOVX) - Stock Titan
Published on: 2026-03-22 08:06:31 - baoquankhu1.vn
Loss Report: Does GeoVax Labs Inc Equity Warrant stock benefit from AI growth2026 Trading Recap & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Short Squeeze: What is First Horizon Corporations debt to equity ratioProduct Launch & Daily Stock Trend Watchlist - baoquankhu1.vn
Pharma News: Is GeoVax Labs Inc Equity Warrants ROE strong enough2026 Stock Rankings & Weekly High Conviction Ideas - baoquankhu1.vn
GeoVax Announces European Society of Medicine Publication Highlighting GEO-CM04S1 as a Next-Generation COVID-19 Vaccine for Immunocompromised Patients - Yahoo Finance
GeoVax Engages Global Health Organizations for Future Mpox/Smallpox Vaccine Procurement - citybuzz -
How The Story On GeoVax Labs (GOVX) Is Shifting Toward Execution Risk And Funding Constraints - Yahoo Finance
GeoVax Initiates Outreach Regarding Future Procurement of GEO-MVA Mpox/Smallpox Vaccine - Yahoo Finance
Geovax Labs Inc Stock (GOVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):